BenQ Medical Technology

BenQ Medical Technology FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of BenQ Medical Technology (4116.TWO) as of Nov 16, 2026 is 331.97 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 44.59 % — a change of 644.58% (higher).

FCF Conversion

331.97 %

YoY

644.58%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of BenQ Medical Technology is 2025 331.97 % . FCF Conversion Rate (FCF/EBITDA) of BenQ Medical Technology was 2024 44.59 % . It decreases by 644.58% higher compared to the previous year.

The BenQ Medical Technology FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
142.08 TWD
Jan 1, 2019
196.38 TWD
Jan 1, 2020
175.85 TWD
Jan 1, 2021
306.60 TWD
Jan 1, 2022
176.83 TWD
Jan 1, 2023
264.50 TWD
Jan 1, 2024
44.59 TWD
Jan 1, 2025
331.97 TWD
The BenQ Medical Technology FCF Conversion history
YEARFCF ConversionYoY
331.97 %+644.58%
44.59 %-83.14%
264.50 %+49.58%
176.83 %-42.33%
306.60 %+74.36%
175.85 %-10.46%
196.38 %+38.22%
142.08 %-268.41%
-84.37 %-56.64%
-194.56 %+251.89%
-55.29 %-178.54%
70.40 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BenQ Medical Technology Stock analysis

What does BenQ Medical Technology do? BenQ Medical Technology Corp. generates revenue through the manufacturing, assembly, maintenance, repair, and sales of medical equipment and consumables. Its primary products include operating tables, out-patient check-in tables, surgical gloves, wound drainage sets, breathing tubes, breathing masks, gynecological examination tables, halogen surgical lights, LED lights, surgical room image and information integration systems, transfusion consumables, and portable ultrasonic wave products. The company distributes these products domestically and to overseas markets such as Asia, the Americas, and Europe, targeting hospitals, clinics, and healthcare facilities that require surgical and clinical equipment. The firm's product portfolio serves surgical rooms and various clinical examination rooms, with key items like halogen surgical lights, LED lights, and surgical room image and information integration systems being central to its offerings. Medical equipment sales drive revenue, focusing on both domestic and international healthcare providers across multiple regions. Products such as surgical gloves and wound drainage sets cater to routine clinical needs, while portable ultrasonic wave products support diagnostic applications in diverse medical settings. BenQ Medical Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BenQ Medical Technology stock

FCF Conversion Rate (FCF/EBITDA) of BenQ Medical Technology is 331.97 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of BenQ Medical Technology changed from 44.59 % to 331.97 %, representing a 644.58% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) BenQ Medical Technology since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s BenQ Medical Technology with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — BenQ Medical Technology

All Key Metrics — BenQ Medical Technology